deCODE Breast CancerTM
deCODE Breast CancerTM identifies 7 widely
replicated genetic variants (SNPs) that are
associated with increased risk of developing
common breast cancer, independent of family
history.
These SNPs contribute to the incidence
of...
More
deCODE Breast CancerTM
deCODE Breast CancerTM identifies 7 widely
replicated genetic variants (SNPs) that are
associated with increased risk of developing
common breast cancer, independent of family
history.
These SNPs contribute to the incidence
of anestimated 60 percent of all breast cancers.
It is a novel, noninvasive, DNA-based reference
laboratory test that offers physicians the
opportunityto begin screening or initiate early
treatment in those who are at increased risk.
BRCA 1 and BRCA 2Common
Mutation
.
BreastSafe® Test
This special logic-based profiling test improves the
sensitivity of breast cancer diagnosis by identifying
the lumps at a very early stage before any symptoms
appear.
Her 2 Gene Amplification
Women with HER2-positive breast cancer (not passed to
the family) have a more aggressive disease, greater
likelihood of recurrence, poorer prognosis, and decreased
survival compared to women with HER2-negative breast
cancer.
It is thus an important diagnosis for the tr
Less